Form 4: DexCom EVP Jacob Steven Leach Reports Changes in Beneficial Ownership
SEC Form 4
DexCom's EVP, Chief Operating Officer Jacob Steven Leach, reports acquisition of shares through restricted stock units and holdings in a family trust.
Summary
- Jacob Steven Leach, EVP and Chief Operating Officer of DexCom Inc., filed a Form 4 detailing changes in beneficial ownership.
- The report indicates the acquisition of 35,906 shares of common stock through a restricted stock unit grant on March 8, 2025, vesting in three equal annual installments.
- An additional 22,798 shares were acquired through another restricted stock unit grant on the same date, vesting over a period until March 8, 2027.
- Following these transactions, Leach directly owns 327,573 shares of DexCom common stock, including 84,537 unvested restricted stock units.
- Leach also indirectly owns 47,296 shares through the Gregg Family Grandchildren's Trust UAD 12/30/2010, where his spouse is a trustee.
Sentiment
Score: 6
Explanation: The sentiment is neutral as it reflects standard executive compensation practices. The acquisition of shares by an executive is generally viewed as a positive sign, but it's a routine occurrence.
Positives
- The acquisition of shares by a key executive could be interpreted positively, signaling confidence in the company's future performance.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies like DexCom. It provides transparency regarding the holdings of key personnel.
Comparison to Industry Standards
- Executive compensation packages including restricted stock units are standard practice among publicly listed companies, particularly in the technology and healthcare sectors.
- Companies like Medtronic, Abbott, and Boston Scientific also utilize similar equity-based compensation to align executive interests with shareholder value.
- The vesting schedules and grant sizes are generally benchmarked against peer companies to attract and retain top talent.
Stakeholder Impact
- The disclosure provides transparency to shareholders regarding executive compensation and ownership.
Key Dates
| Date | Description |
|---|---|
| 12/30/2010 | Date of the Gregg Family Grandchildren's Trust UAD. |
| 03/08/2023 | Date of restricted stock units grant that shall vest through March 8, 2026. |
| 03/08/2024 | Date of restricted stock units grant that shall vest through March 8, 2027. |
| 02/28/2025 | Date of shares acquired under the Issuer's 2015 Employee Stock Purchase Plan. |
| 03/08/2025 | Date of transaction: Grant of restricted stock units. |
| 03/08/2026 | Date when 1/2 of the restricted stock units granted on March 8, 2025 shall vest. |
| 05/22/2026 | Date when 1/8 of the restricted stock units granted on March 8, 2025 shall vest. |
| 08/22/2026 | Date when 1/8 of the restricted stock units granted on March 8, 2025 shall vest. |
| 11/08/2026 | Date when 1/8 of the restricted stock units granted on March 8, 2025 shall vest. |
| 03/08/2027 | Date when the remaining balance of the restricted stock units granted on March 8, 2025 shall vest. |
| 03/08/2028 | Date when restricted stock units granted on March 8, 2025 shall vest. |
| 03/11/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.